drugset / Trial / NCT01040845

A Pharmacokinetic Study of Colchicine With an Oral Contraceptive

NCT01040845

Phase 1 Completed 30 enrolled Mutual Pharmaceutical Company, Inc.
RandomizedCrossoverDouble-blindBasic science

Summary

This study will evaluate the effect, if any, of twice daily dosing of colchicine 0.6 mg at steady state on the steady state pharmacokinetic profile of ethinyl estradiol and norethindrone (Ortho-Novum 1/35). It will also evaluate the effects, if any, of steady state ethinyl estradiol and norethindrone on colchicine at steady state. Finally, this study will assess the safety and tolerability of concurrent use of colchicine and an estrogen/progesterone-containing oral contraceptive.

Timeline

Start
2007-08
Primary completion
2008-01
Completion
2008-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.6 mg Oral
Subject Norethindrone Unknown 1 mg Oral
Subject ethinyl estradiol Small molecule 0.035 mg Oral

Indications

No indication recorded.